These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6768370)

  • 21. In vitro investigation of sodium diclofenac adsorption on sucralfate.
    Grimling B; Pluta J
    Acta Pol Pharm; 2006; 63(6):515-20. PubMed ID: 17438869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study on interaction of gastrointestinal agents in the presence of cytoprotective drugs. Part III. In vitro study on the adsorption of selected prokinetic drugs on sucralfate.
    Grimling B; Pluta J
    Acta Pol Pharm; 2005; 62(1):69-73. PubMed ID: 16022497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sucralfate and soluble sucrose octasulfate bind and stabilize acidic fibroblast growth factor.
    Volkin DB; Verticelli AM; Marfia KE; Burke CJ; Mach H; Middaugh CR
    Biochim Biophys Acta; 1993 Nov; 1203(1):18-26. PubMed ID: 7692970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sucralfate (Ulcogant). Mechanism of action of a cytoprotective agent].
    Steiner KF
    Fortschr Med; 1983 Dec; 101(46):2153-6 contd. PubMed ID: 6689310
    [No Abstract]   [Full Text] [Related]  

  • 25. Adsorption of pepsin by aluminum hydroxide I: Adsorption mechanism.
    Sepelyak RJ; Feldkamp JR; Moody TE; White JL; Hem SL
    J Pharm Sci; 1984 Nov; 73(11):1514-7. PubMed ID: 6440979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A kinetic study of bovine haemoglobin hydrolysis by pepsin immobilized on a functionalized alumina to prepare hydrolysates containing bioactive peptides.
    Ticu EL; Vercaigne-Marko D; Huma A; Artenie V; Toma O; Guillochon D
    Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):199-208. PubMed ID: 15032740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytoprotection by sucralfate: role of sulfate ions.
    Orlando RC; Tobey NA; Schreiner VJ; Powell DW
    Scand J Gastroenterol Suppl; 1987; 140():23-7. PubMed ID: 3481882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sucralfate: pharmacokinetics, metabolism and selective binding to experimental gastric and duodenal ulcers in animals.
    Steiner K; Bühring KU; Faro HP; Garbe A; Nowak H
    Arzneimittelforschung; 1982; 32(5):512-8. PubMed ID: 6896647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of sucralfate and ranitidine on aluminum concentrations in elderly volunteers.
    Moore JG; Coburn JW; Sanders MC; McSorley DJ; Sirgo MA
    Pharmacotherapy; 1995; 15(6):742-6. PubMed ID: 8602382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experimental and clinical studies on anti-pepsin preparation. I. Anti-pepsin and anti-ulcerogenic activities of sucrose sulfate ester].
    Miyoshi A; Moriga M; Kobayashi M; Suyama T; Kiguchi Y
    Naika Hokan; 1968 Dec; 15(12):419-25. PubMed ID: 4886799
    [No Abstract]   [Full Text] [Related]  

  • 31. Sucralfate: a review of drug tolerance and safety.
    Fisher RS
    J Clin Gastroenterol; 1981; 3(Suppl 2):181-4. PubMed ID: 7033354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosal protective effects of ecabet sodium: pepsin inhibition and interaction with mucus.
    Pearson JP; Roberts NB
    Clin Sci (Lond); 2001 Apr; 100(4):411-7. PubMed ID: 11256980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicenter, double-blind trial of sucralfate and placebo in duodenal ulcer.
    McHardy GG
    J Clin Gastroenterol; 1981; 3(Suppl 2):147-52. PubMed ID: 7033351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pepsin immobilized on inorganic supports for the continuous coagulation of skim milk.
    Taylor MJ; Cheryan M; Richardson T; Olson NF
    Biotechnol Bioeng; 1977 May; 19(5):683-700. PubMed ID: 15678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro adsorption of bile salts and aspirin to sucralfate.
    Graham DY; Sackman JW; Giesing DH; Runser DJ
    Dig Dis Sci; 1984 May; 29(5):402-6. PubMed ID: 6546915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of interaction of gastrointestinal agents in the presence of cytoprotective drugs. Part II. In vitro study on the adsorption of selected spasmolytic drugs on sucralfate.
    Pluta J; Grimling B
    Acta Pol Pharm; 2001; 58(6):473-9. PubMed ID: 12197622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical sucralfate in the treatment of vaginal ulceration.
    Lentz SS; Barrett RJ; Homesley HD
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):869-71. PubMed ID: 8469503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies of various saccharide sulfate esters as therapeutic agents for peptic ulcer. 2. Synthesis of an aluminum complex of starch hydrolysate sulfate ester and its antipeptic, antiulcerogenic and anticoagulant properties].
    Sugiura M; Kitamikado T; Yamamoto H; Miyake J
    Nihon Yakurigaku Zasshi; 1973 Sep; 69(5):695-700. PubMed ID: 4587297
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapy of peptic ulcer with cytoprotective substances].
    Fortunat W
    Wien Med Wochenschr; 1983; 133(4-5):94-8. PubMed ID: 6407215
    [No Abstract]   [Full Text] [Related]  

  • 40. A thin layer of sucrose octasulfate protects the oesophageal mucosal epithelium in reflux oesophagitis.
    Hayakawa T; Kawasaki S; Hirayama Y; Tsutsui T; Sugiyama E; Adachi K; Kon R; Suematsu M; Sugiura Y
    Sci Rep; 2019 Mar; 9(1):3559. PubMed ID: 30837505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.